BigHat presents at AI for Drug Discovery 2021 conference

Read more

BigHat founder Mark DePristo spoke about “Antibody design using synthetic biology and machine learning at BigHat Biosciences” at SMI’s AI in Drug Discovery 2021 conference. Topics covered:

  • An introduction to AI/ML in drug discovery
  • An overview of the outstanding challenges in antibody design and engineering
  • Integrating a high-speed wet lab and machine learning for antibody design and engineering
  • Case studies of creating antibodies on BigHat's platform

Watch the talk on BigHat's YouTube channel or view the slides.